ADVANCED HEALTHCARE TECHNOLOGIES, INC., (OTCBB: AVHC)

Dear Reader,

We’ve been publishing StockUpTicks for several years and I’ve written a lot of our editorials and profiles. There’s something interesting in most every story we do and I enjoy drawing your attention to these often-undiscovered stories.

But not like today.

Today I write you from the first person; from my own personal story and experience. 

A short while ago I was with my cousin who is among my dearest friends. I grew up just three doors down from him and his brothers, the eldest of which is Ken, who had been hospitalized battling severe diabetes and a wound that wouldn’t heal. I was with Ken’s brother when he took a call from their father, my uncle, who was at the hospital

Through the mobile phone I could hear my uncle in tears, telling my cousin that they wanted to take Ken’s leg; that amputation looked to be the only cure for a diabetic wound that wouldn’t heal. “Don’t let them take his foot, son,” my elderly uncle told my cousin, imploring him to plead with the doctors to try something else.

When I spoke to Phillip Loori, President of Advanced Healthcare Technologies, Inc. (OTCBB: AVHC) the first time, he told me about his company’s use of Hyperbaric Oxygen Therapy to treat diabetic wounds that wouldn’t heal.  I told him about Ken’s plight and he kindly offered to do whatever he could to help.

I hung up the phone, called my cousin and said that this CEO had told me about a therapy that could save Ken’s limb. I told him about Hyperbaric Oxygen Therapy and what it was designed to do, how it might be perfect for Ken. 

He interrupted me and said, “He’s fine now. That’s what saved his foot. They didn’t have to amputate.”

It’s one thing to hear about FDA approvals and clinical trials.  It’s another to know that the technology that our featured company today is based upon is the reason your loved one still can walk.

I hope you enjoy today’s profile.
 

- ABOUT AVHC -

Advanced Healthcare Technologies is a company that engages in the acquisition of leading technologies in the healthcare industry. Principle acquisition targets consist of companies in the Medical Devise and Medical Service Industry. Recent Acquisitions include: Advanced Hyperbaric Technologies of Farmingdale, NJ. Advanced Hyperbaric engages in the sale of Topical Hyperbaric Oxygen chambers, which are marketed to various healthcare organizations including, wound care clinics and physical therapy providers. AHT's principle products include a portable topical Hyperbaric Oxygen chamber and a The Disposable Sacral Topical Hyperbaric Oxygen System for smaller wounds.

- THIS WEEK'S NEWS FROM AVHC -

Press Release
Source: Advanced Hyperbaric Technologies, Inc.
Wednesday November 20, 7:48 pm ET 

FARMINGDALE, N.J., Nov. 20 /PRNewswire/ -- Advanced Hyperbaric Technologies, Inc., a subsidiary of Advanced Healthcare Technologies, Inc. (OTC Bulletin Board: AVHC - News) today announces the publishing of a new topical hyperbaric oxygen study.

New Topical Hyperbaric Oxygen Study Published-

A study, published this week in a leading medical journal, reports that treatments using AHT 's Topical Hyperbaric Oxygen Products facilitate wound healing and the full closure of pressure ulcers (bed sores) in patients at long term care facilities (nursing homes). The study was conducted by leading wound care researchers and specialists. The study, conducted over a four-week period, demonstrated a 34.4% decrease in the average size of Stage III and Stage IV ulcers by utilizing THBO Therapy. This is highly significant, as many of these wound ulcers can remain open for years. The study went on to show that by healing wounds with THBO Therapy, suffering was reduced and quality of life was improved.

To read the entire release and disclaimer, Click Here

Oxygen: The body's fundamental mechanism for healing itself. It is essential for any healing process - especially chronic, recalcitrant open wounds. Oxygen is vital in collagen synthesis, enhancement of fibroblasts, angiogenesis and leucocyte function. 

Topical Hyperbaric Oxygen: Raises tissue oxygen levels at the wound site. 

The Topical Hyperbaric Oxygen Extremity Chamber: Pulses topical hyperbaric oxygen at intermittent pressure directly to the wound site. The result is oxygen levels are raised, wounds heal faster and the cost to heal the wound is drastically reduced.
 

Currently, AVHC is conducting research at two facilities that specialize in wound healing and wound healing research.

One of the main goals of studies of this type is to generate clinical information necessary for Medicare and other insurance providers to pay for Topical Hyperbaric Oxygen Therapy in patient's homes as well as on an outpatient basis.  The second research project is slated to begin in December. AHT plans to commit resources to the Northeast Center for Special Care, a 250-bed spinal cord injury center. In the study, researchers will investigate the clinical efficacy of both the disposable sacral chamber and the extremity chamber.  The third research project is slated to begin in January and will begin at a large Wound Care Center in New York. The research project will be a 100-patient controlled study. A controlled study of this size is significant as clinicians, when evaluating treatments, look for controlled studies with large numbers of patients treated.

- THE MARKETS FOR AVHC INNOVATION -

AVHC has already signed a distribution agreement with Innovative Medical Systems, Inc. of St. Louis,  Missouri, a medical distributor, which is marketing the chambers in the states of Illinois, Missouri and Kansas. 

As AVHC continues to increase its sales efforts in the United States they are beginning to focus on an even greater marketing opportunity, the international market. AVHC is currently selling its products in Canada, Spain and Israel. 

AVHC is communicating with medical device distributors in Japan, Jordan and Ireland who have contacted the company seeking the opportunity to market the chambers in their respective countries. Additionally, AHT is working toward a strategic partner relationship with an overseas company to be the master distributor of its THBO products in Europe. 

The European market is of great interest to AVHC as diabetic foot ulcers continue to be the most common cause of lower extremity amputations in Europe. 
 

- COMPARATIVE TREATMENTS -

What is the advantage of utilizing THBO instead of Full Body HBO?  The advantage of Topical delivery of Hyperbaric Oxygen is the ability to achieve increased oxygen tension in the wound without the risk of oxygen toxicity. There is no systemic absorption when using the topical HBO chamber. When using the Full Body Chamber, you are breathing the oxygen, and by doing so, you are directly exposing yourself or the patient to the risk of central nervous system or pulmonary toxicity, both of which have been reported in patients who have been treated in Full Body Chambers. 

Are there any side effects?                          Full Body                            Topical HBO
Congestive Heart Failure                                 Yes                                         No
Severe Claustrophobia                                     Yes                                         No
Congestive Heart Failure                                 Yes                                         No

Nervous System Disorders                               Yes                                         No
Accelerates Cataract Growth                           Yes                                         No

Distorts Vision up to 8 week                            Yes                                          No
Pressure in the Ears and Sinus Cavity              Yes                                          No

Most private insurance companies, including some Medicare and Medicaid HMO Plans are approving Topical Hyperbaric Oxygen Therapy on a case by case basis for home car use. A prescription and a Letter of Medical Necessity are required in order to start the pre-approval process. 

Traditional Medicare and Medicaid plans currently do not cover Topical Hyperbaric Oxygen Therapy in the home. However, therapy can be administered on an out-patient basis at the doctors office or at a Wound Care Center. Additionally patients receive treatment when they are in-patients in a hospital or a nursing home. 

If private insurance reimbursement in unavailable or traditional Medicare is the only insurance, reasonable monthly rental rates can be arranged to accommodate someone's needs. 

- SELECTED FINANCIAL HIGHLIGHTS -

Market Cap. 2.63 million
Shares Outstanding: 14,007,000

52-Week High 1.0500 (04-24-02)
52-Week Low 0.1800 (10-10-02)
Recent Price: 0.28
Avg. Daily Volume: 31,700

HISTORICAL BUSINESS INFORMATION: The Company was incorporated on March 28, 2000 under the laws of the State of Colorado. Shareholders were asked to approve a name change to Mariner Health Care, Inc. to  more accurately reflect the proposed business of the Company to assist in the development of new healthcare technologies.  On May 24, 2002 the Company announced they have authorized a 5 for 1 forward stock split. The Company changed  its corporate domicile from Colorado to Nevada. On June 21, 2002 the Company announced in a press release that it had identified numerous opportunities in the healthcare industry, therefore, the company would cease its operations in the Mortgage industry and use its assets and experience, while bringing on new management, to engage in the development and incubation of small public and  private companies in the healthcare industry.  On July 17, 2002 the Company changed its name to Mariner Healthcare Inc. On August 5, 2002, the Company changed its name to Advanced Healthcare  Technologies, Inc. and applied for a new symbol and cusip number. In August, 2002, the Company completed its due diligence period and elected to  move forward with the acquisition of Advanced Hyperbaric Technologies Inc. On August 5, 2002 the Company announced that the final documents pertaining to its acquisition of Advanced Hyperbaric Technologies, Inc. had been completed in the stock  for stock transaction. Advanced Hyperbaric Technologies continues to operate as a subsidiary of AVHC.

To view the SEC filings for AVHC (Still being filed as Mariner Health Care) Click Here

To get a current quote and a list of recent press releases, Click Here
 

- CONTACT -

Advanced Healthcare Technologies
          124 Colts Neck Road
         Farmingdale, NJ 07727

Company Contact: Phillip Loori
Tel: 800-327-4325
Email: philliploori@aol.com

Brokers and Analysts: Guy Vinci, Tel: 866-730-9604

Visit the Advanced Healthcare Technologies, Inc. Web site at: www.advancedhealthcaretechnologies.com 

Visit the Advanced Hyperbaric Technologies Web site at: www.advanced-hyperbaric.com 

Disclaimer: StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated (MP).  The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness.  Past performance is no guarantee of future results. This report is a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision. MP has been compensated with 192,000 shares of common stock of Advanced Healthcare Technologies, Inc., by ARB Consulting, Inc., for preparation and distribution of this report and other advertising services. This constitutes a conflict of interest as to MP’s ability to remain objective in its communication regarding the subject company.  Write or call MP for detailed disclosure as required by Rule 17b of the Securities Act of 1933/1934.  MP is not an investment advisor and this report is not investment advice. This information is neither a solicitation to buy nor an offer to sell securities but is a paid advertisement.  Information contained herein contains forward-looking statements and is subject to significant risks and uncertainties, which will affect the results.  The opinions contained herein reflect our current judgment and are subject to change without notice. MP and/or its affiliates, associates and employees from time to time may have either a long or short position in securities mentioned.  Information contained herein may not be reproduced in whole or in part without the express written consent of Market Pathways Financial Relations Incorporated.